Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children
The purpose of this study is to compare two preoperative chemotherapy regimens based on high-dose methotrexate courses given alternately either with doxorubicin or with etoposide-ifosfamide.
Osteosarcoma|Localised High Grade Osteosarcoma of the Limbs
DRUG: Etoposide, Ifosfamide, Methotrexate|DRUG: Doxorubicin, Methotrexate
Good histological response (5% or less viable cells) after preoperative chemotherapy
Event-free survival,|Overall survival,|Toxicity.
The purpose of this study is to compare two preoperative chemotherapy regimens based on high-dose methotrexate courses given alternately either with doxorubicin or with etoposide-ifosfamide.